A detailed history of Peak6 Investments LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Peak6 Investments LLC holds 90,900 shares of CRSP stock, worth $4.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
90,900
Previous 185,800 51.08%
Holding current value
$4.35 Million
Previous $10 Million 57.44%
% of portfolio
0.01%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$44.62 - $62.75 $13,252 - $18,636
297 New
297 $13,000
Q4 2023

Feb 13, 2024

SELL
$38.62 - $72.18 $901,892 - $1.69 Million
-23,353 Reduced 99.26%
175 $10,000
Q3 2023

Nov 13, 2023

BUY
$45.39 - $59.0 $624,929 - $812,312
13,768 Added 141.07%
23,528 $1.07 Million
Q2 2023

Aug 11, 2023

SELL
$43.47 - $67.77 $1.75 Million - $2.73 Million
-40,256 Reduced 80.49%
9,760 $547,000
Q1 2023

May 12, 2023

SELL
$41.0 - $56.12 $9.09 Million - $12.4 Million
-221,829 Reduced 81.6%
50,016 $2.26 Million
Q4 2022

Feb 10, 2023

BUY
$39.19 - $65.67 $10.7 Million - $17.9 Million
271,845 New
271,845 $11.1 Million
Q2 2022

Aug 12, 2022

SELL
$43.23 - $73.83 $6.84 Million - $11.7 Million
-158,146 Reduced 92.04%
13,686 $832,000
Q1 2022

May 13, 2022

BUY
$53.19 - $79.24 $3.2 Million - $4.76 Million
60,114 Added 53.81%
171,832 $10.8 Million
Q4 2021

Feb 11, 2022

BUY
$70.09 - $111.29 $4.57 Million - $7.26 Million
65,193 Added 140.12%
111,718 $8.47 Million
Q3 2021

Nov 12, 2021

BUY
$110.2 - $156.64 $725,226 - $1.03 Million
6,581 Added 16.48%
46,525 $5.21 Million
Q1 2021

May 14, 2021

BUY
$110.72 - $210.04 $4.42 Million - $8.39 Million
39,944 New
39,944 $4.87 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.74B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.